These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Spectrum and impact of checkpoint inhibitor-induced irAEs. Cappelli LC; Bingham CO Nat Rev Rheumatol; 2021 Feb; 17(2):69-70. PubMed ID: 33235330 [No Abstract] [Full Text] [Related]
8. Rheumatic adverse events of immune checkpoint inhibitors in cancer immunotherapy. Abdel-Wahab N; Suarez-Almazor ME Expert Rev Clin Immunol; 2024 Aug; 20(8):873-893. PubMed ID: 38400840 [TBL] [Abstract][Full Text] [Related]
9. Rheumatic Complications of Immune Checkpoint Inhibitors. Ghosh N; Bass AR Rheum Dis Clin North Am; 2022 May; 48(2):411-428. PubMed ID: 35400368 [TBL] [Abstract][Full Text] [Related]
10. Management of rheumatic complications of ICI therapy: a rheumatology viewpoint. Leipe J; Mariette X Rheumatology (Oxford); 2019 Dec; 58(Suppl 7):vii49-vii58. PubMed ID: 31816078 [TBL] [Abstract][Full Text] [Related]
11. An MRI study of immune checkpoint inhibitor-induced musculoskeletal manifestations myofasciitis is the prominent imaging finding. Daoussis D; Kraniotis P; Filippopoulou A; Argiriadi R; Theodoraki S; Makatsoris T; Koutras A; Kehagias I; Papachristou DJ; Solomou A; Kalofonos H; Liossis SN Rheumatology (Oxford); 2020 May; 59(5):1041-1050. PubMed ID: 32344435 [TBL] [Abstract][Full Text] [Related]
12. Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy. Abdel-Wahab N; Suarez-Almazor ME Rheumatology (Oxford); 2019 Dec; 58(Suppl 7):vii40-vii48. PubMed ID: 31816084 [TBL] [Abstract][Full Text] [Related]
13. Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature. Benfaremo D; Manfredi L; Luchetti MM; Gabrielli A Curr Drug Saf; 2018; 13(3):150-164. PubMed ID: 29745339 [TBL] [Abstract][Full Text] [Related]
14. Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial Tumors. Mullenix C; Ballman M; Chen H; Swift S; McAdams MJ; Tsai YT; Donahue RN; Poretta T; Gupta S; Loehrer PJ; Schlom J; Gulley JL; Rajan A Oncologist; 2022 Apr; 27(4):e353-e356. PubMed ID: 35380721 [TBL] [Abstract][Full Text] [Related]
19. Immune-Related Adverse Effects of Cancer Immunotherapy- Implications for Rheumatology. Cappelli LC; Shah AA; Bingham CO Rheum Dis Clin North Am; 2017 Feb; 43(1):65-78. PubMed ID: 27890174 [TBL] [Abstract][Full Text] [Related]
20. Rheumatic Manifestations and Diseases From Immune Checkpoint Inhibitors in Cancer Immunotherapy. Shen P; Deng X; Hu Z; Chen Z; Huang Y; Wang K; Qin K; Huang Y; Ba X; Yan J; Han L; Tu S Front Med (Lausanne); 2021; 8():762247. PubMed ID: 34805229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]